Solution Group to supply CanSino vaccine in Malaysia

Solution Group Bhd’s (SGB) wholly-owned subsidiary Solution Biologics Sdn Bhd (Solbio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine for use against Covid-19.

In a statement, the group said the finished product agreement allows Solbio to purchase and CanSino to supply the finish product vaccine for emergency use in Malaysia...

Unlocking Article

Show your support for robust journalism

Millions depend on Malaysiakini for the truth. Millions depend on Malaysiakini for quality journalism. Millions depend on Malaysiakini to stand in honour of integrity and justice.

Without a mafia owner to dictate our journalism; free from political or commercial influence, Malaysiakini has only one boss - you, the rakyat.

We take this opportunity to thank you for your love for our country, your trust and respect in us to do our job in holding the powerful to account. We depend on your subscription to protect the sanctity of our journalism. Thank you.

Malaysiakini Team

Read more from this author :
View Comments
Most Read
Most Commented
Most Recent